{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T02:56:29Z","timestamp":1777776989219,"version":"3.51.4"},"reference-count":21,"publisher":"Walter de Gruyter GmbH","issue":"2","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>A 58-year-old woman with a history of Sjogren\u2019s syndrome was admitted to our hospital with cough, decreased right lung breath sounds and arthralgia in both thumbs. Chest computed tomography showed consolidation with air bronchogram in the right lung. Levels of anti-cyclic citrullinated peptide antibody and rheumatoid factor levels were significantly elevated. She was diagnosed with rheumatoid arthritis induced by bacterial organizing pneumonia. Treatment with salazosulfapyridine was added for rheumatoid arthritis and arthralgia gradually improved. This case highlights that respiratory infections could lead to anti-cyclic citrullinated peptide antibody-positive rheumatoid arthritis in patients with Sjogren\u2019s syndrome.<\/jats:p>","DOI":"10.2478\/rjim-2022-0003","type":"journal-article","created":{"date-parts":[[2022,1,29]],"date-time":"2022-01-29T10:23:13Z","timestamp":1643451793000},"page":"127-131","source":"Crossref","is-referenced-by-count":0,"title":["Anti-cyclic citrullinated peptide antibody-positive rheumatoid arthritis caused by bacterial organizing pneumonia in a patient with Sjogren\u2019s syndrome"],"prefix":"10.2478","volume":"60","author":[{"given":"Taro","family":"Horino","sequence":"first","affiliation":[{"name":"Department of Endocrinology, Metabolism and Nephrology , Kochi Medical School, Kochi University , Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuharu","family":"Yoshida","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Metabolism and Nephrology , Kochi Medical School, Kochi University , Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Inotani","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Metabolism and Nephrology , Kochi Medical School, Kochi University , Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuki","family":"Anabuki","sequence":"additional","affiliation":[{"name":"Department of Hematology and Respiratory Medicine , Kochi Medical School, Kochi University , Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Ohnishi","sequence":"additional","affiliation":[{"name":"Department of Hematology and Respiratory Medicine , Kochi Medical School, Kochi University , Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Komori","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology , Kochi Medical School, Kochi University , Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osamu","family":"Ichii","sequence":"additional","affiliation":[{"name":"Laboratory of Anatomy , Department of Biomedical Sciences, Graduate School of Veterinary Medicine , Hokkaido University , Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshio","family":"Terada","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Metabolism and Nephrology , Kochi Medical School, Kochi University , Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","published-online":{"date-parts":[[2022,6,14]]},"reference":[{"key":"2026042915193783240_j_rjim-2022-0003_ref_001","doi-asserted-by":"crossref","unstructured":"1. VITALI C., BOMBARDIERI S., JONSSON R., MOUTSOPOULOS HM., ALEXANDER EL., CARSONS SE., et al. Classification criteria for Sj\u00f6gren\u2019s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis. 2002;61(6):554\u20138.10.1136\/ard.61.6.554175413712006334","DOI":"10.1136\/ard.61.6.554"},{"key":"2026042915193783240_j_rjim-2022-0003_ref_002","doi-asserted-by":"crossref","unstructured":"2. ALANI H., HENTY JR., THOMPSON NL., JURY E., CIURTIN C. Systematic review and meta-analysis of the epidemiology of polyautoimmunity in Sj\u00f6gren\u2019s syndrome (secondary Sj\u00f6gren\u2019s syndrome) focusing on autoimmune rheumatic diseases. Scand J Rheumatol. 2018;47(2):141\u201354.10.1080\/03009742.2017.132490928927315","DOI":"10.1080\/03009742.2017.1324909"},{"key":"2026042915193783240_j_rjim-2022-0003_ref_003","doi-asserted-by":"crossref","unstructured":"3. BROWN LE., FRITS ML., IANNACCONE CK., WEINBLATT ME., SHADICK NA., LIAO KP. Clinical characteristics of RA patients with secondary SS and association with joint damage. Rheumatology (Oxford). 2015;54(5):816\u201320.10.1093\/rheumatology\/keu400441608325313147","DOI":"10.1093\/rheumatology\/keu400"},{"key":"2026042915193783240_j_rjim-2022-0003_ref_004","doi-asserted-by":"crossref","unstructured":"4. KIM SM., PARK E., LEE JH., LEE SH., KIM HR. The clinical significance of anti-cyclic citrullinated peptide antibody in primary Sj\u00f6gren syndrome. Rheumatol Int. 2012;32(12):3963\u20137.10.1007\/s00296-011-2274-322205381","DOI":"10.1007\/s00296-011-2274-3"},{"key":"2026042915193783240_j_rjim-2022-0003_ref_005","doi-asserted-by":"crossref","unstructured":"5. LEE J., KOH JH., KIM JW., SUNG YK., LEE SS., CHOE JY., et al. Performance of the 2016 ACR-EULAR classification criteria for primary Sjogren\u2019s syndrome in a Korean cohort. Rheumatol Int. 2018;38(9):1651\u201360.10.1007\/s00296-018-4109-y30030624","DOI":"10.1007\/s00296-018-4109-y"},{"key":"2026042915193783240_j_rjim-2022-0003_ref_006","doi-asserted-by":"crossref","unstructured":"6. TEN BRINCK RM., VAN STEENBERGEN HW., VAN DELFT MAM., VERHEUL MK., TOES REM., TROUW LA., et al. The risk of individual autoantibodies, autoantibody combinations and levels for arthritis development in clinically suspect arthralgia. Rheumatology (Oxford). 2017;56(12):2145\u201353.10.1093\/rheumatology\/kex340670399728968865","DOI":"10.1093\/rheumatology\/kex340"},{"key":"2026042915193783240_j_rjim-2022-0003_ref_007","doi-asserted-by":"crossref","unstructured":"7. NISHIMURA K., SUGIYAMA D., KOGATA Y., TSUJI G., NAKAZAWA T., KAWANO S., et al. Meta-analysis: diagnostic accuracy of anti-cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis. Ann Intern Med. 2007;146(11):797\u2013808.10.7326\/0003-4819-146-11-200706050-0000817548411","DOI":"10.7326\/0003-4819-146-11-200706050-00008"},{"key":"2026042915193783240_j_rjim-2022-0003_ref_008","doi-asserted-by":"crossref","unstructured":"8. PERRY E., KELLY C., EGGLETON P., DE SOYZA A., HUTCHINSON D. The lung in ACPA-positive rheumatoid arthritis: an initiating site of injury? Rheumatology (Oxford). 2014;53(11):1940\u201350.10.1093\/rheumatology\/keu19524831057","DOI":"10.1093\/rheumatology\/keu195"},{"key":"2026042915193783240_j_rjim-2022-0003_ref_009","doi-asserted-by":"crossref","unstructured":"9. LAPPIN DF., APATZIDOU D., QUIRKE AM., OLIVER-BELL J., BUTCHER JP., KINANE DF., et al. Influence of periodontal disease, Porphyromonas gingivalis and cigarette smoking on systemic anti-citrullinated peptide antibody titres. J Clin Periodontol. 2013;40(10):907\u201315.10.1111\/jcpe.1213823902301","DOI":"10.1111\/jcpe.12138"},{"key":"2026042915193783240_j_rjim-2022-0003_ref_010","doi-asserted-by":"crossref","unstructured":"10. MARESZ KJ., HELLVARD A., SROKA A., ADAMOWICZ K., BIELECKA E., KOZIEL J., et al. Porphyromonas gingivalis facilitates the development and progression of destructive arthritis through its unique bacterial peptidylarginine deiminase (PAD). PLoS Pathog. 2013;9(9):e1003627.10.1371\/journal.ppat.1003627377190224068934","DOI":"10.1371\/journal.ppat.1003627"},{"key":"2026042915193783240_j_rjim-2022-0003_ref_011","doi-asserted-by":"crossref","unstructured":"11. HUTCHINSON D., SHEPSTONE L., MOOTS R., LEAR JT., LYNCH MP. Heavy cigarette smoking is strongly associated with rheumatoid arthritis (RA), particularly in patients without a family history of RA. Ann Rheum Dis. 2001;60(3):223\u20137.10.1136\/ard.60.3.223","DOI":"10.1136\/ard.60.3.223"},{"key":"2026042915193783240_j_rjim-2022-0003_ref_012","doi-asserted-by":"crossref","unstructured":"12. KALLBERG H., DING B., PADYUKOV L., BENGTSSON C., RONNELID J., KLARESKOG L., et al. Smoking is a major preventable risk factor for rheumatoid arthritis: estimations of risks after various exposures to cigarette smoke. Ann Rheum Dis. 2011;70(3):508\u201311.10.1136\/ard.2009.120899","DOI":"10.1136\/ard.2009.120899"},{"key":"2026042915193783240_j_rjim-2022-0003_ref_013","doi-asserted-by":"crossref","unstructured":"13. MAKRYGIANNAKIS D., HERMANSSON M., ULFGREN AK., NICHOLAS AP., ZENDMAN AJ., EKLUND A., et al. Smoking increases peptidylarginine deiminase 2 enzyme expression in human lungs and increases citrullination in BAL cells. Ann Rheum Dis. 2008;67(10):1488\u201392.10.1136\/ard.2007.075192","DOI":"10.1136\/ard.2007.075192"},{"key":"2026042915193783240_j_rjim-2022-0003_ref_014","doi-asserted-by":"crossref","unstructured":"14. KLARESKOG L., STOLT P., LUNDBERG K., KALLBERG H., BENGTSSON C., GRUNEWALD J., et al. A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination. Arthritis Rheum. 2006;54(1):38\u201346.10.1002\/art.21575","DOI":"10.1002\/art.21575"},{"key":"2026042915193783240_j_rjim-2022-0003_ref_015","doi-asserted-by":"crossref","unstructured":"15. KLARESKOG L., RONNELID J., LUNDBERG K., PADYUKOV L., ALFREDSSON L. Immunity to citrullinated proteins in rheumatoid arthritis. Annu Rev Immunol. 2008;26:651\u201375.10.1146\/annurev.immunol.26.021607.090244","DOI":"10.1146\/annurev.immunol.26.021607.090244"},{"key":"2026042915193783240_j_rjim-2022-0003_ref_016","doi-asserted-by":"crossref","unstructured":"16. RUIZ-ESQUIDE V., GOMARA MJ., PEINADO VI., GOMEZ PUERTA JA., BARBERA JA., CANETE JDE D., et al. Anti-citrullinated peptide antibodies in the serum of heavy smokers without rheumatoid arthritis. A differential effect of chronic obstructive pulmonary disease? Clin Rheumatol. 2012;31(7):1047\u201350.10.1007\/s10067-012-1971-y","DOI":"10.1007\/s10067-012-1971-y"},{"key":"2026042915193783240_j_rjim-2022-0003_ref_017","doi-asserted-by":"crossref","unstructured":"17. PABST R., GEHRKE I. Is the bronchus-associated lymphoid tissue (BALT) an integral structure of the lung in normal mammals, including humans? Am J Respir Cell Mol Biol. 1990;3(2):131\u20135.10.1165\/ajrcmb\/3.2.131","DOI":"10.1165\/ajrcmb\/3.2.131"},{"key":"2026042915193783240_j_rjim-2022-0003_ref_018","doi-asserted-by":"crossref","unstructured":"18. PABST R. Is BALT a major component of the human lung immune system? Immunol Today. 1992;13(4):119\u201322.10.1016\/0167-5699(92)90106-H","DOI":"10.1016\/0167-5699(92)90106-H"},{"key":"2026042915193783240_j_rjim-2022-0003_ref_019","doi-asserted-by":"crossref","unstructured":"19. RANGEL-MORENO J., HARTSON L., NAVARRO C., GAXIOLA M., SELMAN M., RANDALL TD. Inducible bronchus-associated lymphoid tissue (iBALT) in patients with pulmonary complications of rheumatoid arthritis. J Clin Invest. 2006;116(12):3183\u201394.10.1172\/JCI28756167882017143328","DOI":"10.1172\/JCI28756"},{"key":"2026042915193783240_j_rjim-2022-0003_ref_020","doi-asserted-by":"crossref","unstructured":"20. BAKA Z., GYORGY B., GEHER P., BUZAS EI., FALUS A., NAGY G. Citrullination under physiological and pathological conditions. Joint Bone Spine. 2012;79(5):431\u20136.10.1016\/j.jbspin.2012.01.00822366145","DOI":"10.1016\/j.jbspin.2012.01.008"},{"key":"2026042915193783240_j_rjim-2022-0003_ref_021","doi-asserted-by":"crossref","unstructured":"21. KAWAHITO Y., ICHINOSE S., SANO H., TSUBOUCHI Y., KOHNO M., YOSHIKAWA T., et al. Mycoplasma fermentans glycolipid-antigen as a pathogen of rheumatoid arthritis. Biochem Biophys Res Commun. 2008;369(2):561\u20136.10.1016\/j.bbrc.2008.02.07918307980","DOI":"10.1016\/j.bbrc.2008.02.079"}],"container-title":["Romanian Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/reference-global.com\/pdf\/10.2478\/rjim-2022-0003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T18:41:50Z","timestamp":1777488110000},"score":1,"resource":{"primary":{"URL":"https:\/\/reference-global.com\/article\/10.2478\/rjim-2022-0003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,1]]},"references-count":21,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2022,6,14]]},"published-print":{"date-parts":[[2022,6,1]]}},"alternative-id":["10.2478\/rjim-2022-0003"],"URL":"https:\/\/doi.org\/10.2478\/rjim-2022-0003","relation":{},"ISSN":["2501-062X"],"issn-type":[{"value":"2501-062X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,1]]}}}